1. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway
   Zhibo Jin et al, 2017, Cell Tissue Res CrossRef
2. Telbivudine attenuates UUO-induced renal fibrosis via TGF-β/Smad and NF-κB signaling.
   Jie Chen et al, 2018, Int Immunopharmacol CrossRef
3. Hesperetin alleviates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro
   Hong-Wei Wang et al, 2017 CrossRef
4. Responses of Intestinal Mucosal Barrier Functions of Rats to Simulated Weightlessness
   Mingliang Jin et al, 2018, Front. Physiol. CrossRef
5. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro
   Xiangjun Zhou et al, 2017, International Immunopharmacology CrossRef
6. Qi-Zhu-Xie-Zhuo-Fang reduces serum uric acid levels and ameliorates renal fibrosis in hyperuricemic nephropathy rats
   Wang Huijuan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
7. FoxM1 inhibition ameliorates renal interstitial fibrosis by decreasing extracellular matrix and epithelial–mesenchymal transition
   Yanhui Wang et al, 2020, Journal of Pharmacological Sciences CrossRef
8. Effect of astragaloside IV and the role of nuclear receptor RXRα in human peritoneal mesothelial cells in high glucose‑based peritoneal dialysis fluids
   Weiwei Zhu et al, 2019, Mol Med Report CrossRef
9. Combination of Matrix Solid Phase Dispersion and Response Surface Evaluation for Simultaneous Detections of Multiple Bioactive Constituents of Traditional Chinese Medicine Formula: Using Baoyuan Capsule as an Example
   Qiaohui Du et al, 2020, Journal of Pharmaceutical and Biomedical Analysis CrossRef
10. Associations Between Using Chinese Herbal Medicine and Long-Term Outcome Among Pre-dialysis Diabetic Nephropathy Patients: A Retrospective Population-Based Cohort Study
    Jenny Chun-Ling Guo et al, 2021, Front. Pharmacol. CrossRef
11. Mechanism of Radix Astragali and Radix Salviae Miltiorrhizae Ameliorates Hypertensive Renal Damage
    Guangjian Hou et al, 2021, BioMed Research International CrossRef
12. Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis
    Xiao-Yuan Liu et al, 2022, Front. Pharmacol. CrossRef
13. A network pharmacology-based study on the mechanism of astragaloside IV alleviating renal fibrosis through the AKT1/GSK-3β pathway
    Xinwei Yu et al, 2022, Journal of Ethnopharmacology CrossRef
14. Astragalus Mongholicus: A review of its anti-fibrosis properties
    Fengying Gong et al, 2022, Front. Pharmacol. CrossRef
15. Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
    Yi Zhu et al, 2022, Front. Pharmacol. CrossRef
16. The telomerase activator TA-65 protects from cigarette smoke-induced small airway remodeling in mice through extra-telomeric effects
    Arnaud Jean Florent Tiendrébéogo et al, 2023, Sci Rep CrossRef
17. Shen Qi Wan-Containing Serum Alleviates Renal Interstitial Fibrosis via Restraining Notch1-Mediated Epithelial-Mesenchymal Transition
    Hongshu Chen et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef
18. Research state of the herbal medicine Huangqi (Radix Astragali): A global and bibliometric study
    Yan-Jun Chen et al, 2024 CrossRef